Hudson Bay Capital Management LP Rocket Pharmaceuticals, Inc. Transaction History
Hudson Bay Capital Management LP
- $28.9 Billion
- Q1 2025
A detailed history of Hudson Bay Capital Management LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 151,200 shares of RCKT stock, worth $948,023. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151,200
Previous 113,500
33.22%
Holding current value
$948,023
Previous $1.43 Million
29.31%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RCKT
# of Institutions
258Shares Held
108MCall Options Held
555KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$111 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$79.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$41.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$38.8 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$32.6 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $475M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...